D-DTTA 盐

D-DTTA 盐性质、用途与生产工艺

D-DTTA 盐 上下游产品信息

上游原料

下游产品

D-DTTA 盐 生产厂家

128173-53-5, D-DTTA 盐 相关搜索:

• 系列1
• 西酞普兰
• 标准品
• 中药对照品
• 杂质对照品
• 对照品
• 艾司西酞普兰
• 艾司西酞普兰杂质Z
• C60H64F2N4O12
• 2C20H23FN2O2C20H18O8
• 草酸艾司西酞普兰EP杂质E(S)-对映异构体半对甲苯酰酒石酸盐
• 艾司西酞普兰相关化合物A
• 艾司西酞普兰相关化合物A D-DTTA盐
• 艾司西酞普兰INT L 艾司西酞普兰-A12
• 艾司西酞普兰 USP 相关化合物 A
• 艾司西酞普兰相关物质A EDTA盐
• 艾司西酞普兰中间体N-2 DTTA盐
• 4-[(4-二甲基氨基)-1-(4-氟苯基)-1-羟基丁基]-3-羟基甲基苯腈D-(+)-二对甲基苯甲酰酒石酸盐
• (-)-4-[4-二甲氨基-1-(4-氟苯基)-1-羟基丁基]-3-羟甲基苯腈 D-(+)-二对甲苯甲酰酒石酸盐
• 依西酞普兰USP相关化合物A
• 西酞普兰 DI羟基杂质
• D-DTTA 盐/艾司西酞普兰中间体
• L-DTTA 盐 (-)-4-[4-二甲氨基-1-(4-氟苯基)-1-羟基丁基]-3-羟甲基苯腈 L-(+)-二对甲苯甲酰酒石酸盐
• 艾司西酞普兰INT L
• 艾司西酞普兰-A12
• 草酸艾司西酞普兰杂质A对照品
• 草酸艾司西酞普兰杂质A
• 草酸艾司西酞普兰USP相关物质A
• 艾司西酞
• (-)-4-[4-二甲氨基-1-(4-氟苯基)-1-羟基丁基]-3-羟甲基苯腈 D-(+)-二对甲苯甲酰酒石酸盐 (2:1)
• 西酞普兰二羟基杂质
• (-)-4-[4-(二甲氨基)-1-(4-氟苯基)-1-羟基丁基] -3-(羟甲基)-苯氰半 D-(+)-二-对-甲苯甲酸盐 (简称:D-DTTA盐)
• D-DTTA 盐 (-)-4-[4-二甲氨基-1-(4-氟苯基)-1-羟基丁基]-3-羟甲基苯腈 D-(+)-二对甲苯甲酰酒石酸盐
• D-DTTA 盐
• 128173-53-5
• (+)-Dipara tolouyl–d-tartaric acid salt of 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile
• Escitalopram Oxalate EP Impurity E as (S)-Enantiomer Ditoluoyltartrate
• (‐)‐4‐(4‐Dimetylamino)‐1‐(4‐ fluorophenyl)‐1‐hydroxybutyl]‐ 3‐(hydroxymethyl)?benzonitrile? ,Hemi?D‐(+)‐Di‐p‐toluoyl?tartaric? acid?salt?(CTS‐I)
• Benzonitrile, 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-, (S)-, (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1)
• (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]-Butanedioic acid compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (9CI ACI)
• Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (9CI, ACI)
• Escitalopram USP Related Compound A as Hemi-di-toluoyltartrate
• (+)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(-)-di-p-toloyltartaric acid salt
• Escitalopram Related Compound A ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydr (1249417)
• (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
• 4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-Hydroxybutyl]-3-(hydroxymethyl)-benzonitile-D-hemi tartari
• (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3...
• (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrilehemiD-(+)-
• 4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile D-hemi tartaricacid salt
• (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid,4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile
• Escitalopram Related Compound A D-DTTA Salt
• 4-((S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile D-DTTA salt
• 4-{4-(Dimethylamino)-[(4'-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)}benzonitrile
• Escitalopram OxalateD-DTTA
• (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
• Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2)
• Escitalopram USP Related Compound A
• EscitalopraM Related CoMpound A